A detailed history of Ameriprise Financial Inc transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 17,730 shares of ARCT stock, worth $318,785. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,730
Previous 19,190 7.61%
Holding current value
$318,785
Previous $467,000 11.99%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$18.08 - $25.38 $26,396 - $37,054
-1,460 Reduced 7.61%
17,730 $411,000
Q2 2024

Aug 14, 2024

BUY
$24.35 - $44.39 $31,776 - $57,928
1,305 Added 7.3%
19,190 $467,000
Q1 2024

May 15, 2024

SELL
$31.23 - $42.99 $229,321 - $315,675
-7,343 Reduced 29.11%
17,885 $603,000
Q4 2023

Feb 14, 2024

BUY
$17.71 - $32.97 $291,205 - $542,125
16,443 Added 187.17%
25,228 $795,000
Q3 2023

Nov 14, 2023

SELL
$25.44 - $37.35 $3,510 - $5,154
-138 Reduced 1.55%
8,785 $224,000
Q2 2023

Aug 14, 2023

BUY
$23.94 - $32.36 $2,753 - $3,721
115 Added 1.31%
8,923 $255,000
Q1 2023

May 15, 2023

SELL
$14.72 - $23.97 $98,947 - $161,126
-6,722 Reduced 43.28%
8,808 $211,000
Q4 2022

Feb 14, 2023

BUY
$14.14 - $23.06 $21,351 - $34,820
1,510 Added 10.77%
15,530 $263,000
Q3 2022

Nov 14, 2022

BUY
$13.05 - $22.13 $182,961 - $310,262
14,020 New
14,020 $208,000
Q4 2021

Feb 14, 2022

SELL
$34.2 - $47.56 $199,386 - $277,274
-5,830 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$27.88 - $58.25 $162,540 - $339,597
5,830 New
5,830 $279,000
Q1 2021

May 17, 2021

SELL
$38.75 - $86.92 $370,411 - $830,868
-9,559 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$34.61 - $123.66 $1.62 Million - $5.78 Million
-46,765 Reduced 83.03%
9,559 $415,000
Q3 2020

Nov 16, 2020

SELL
$37.49 - $63.19 $524,035 - $883,269
-13,978 Reduced 19.88%
56,324 $2.42 Million
Q2 2020

Aug 14, 2020

BUY
$12.66 - $58.27 $890,023 - $4.1 Million
70,302 New
70,302 $3.29 Million

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $478M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.